Pfizer COVID-19 vaccines safe and effective for small children--US FDA staff | Inquirer News

Pfizer COVID-19 vaccines safe and effective for small children–US FDA staff

/ 10:37 AM June 13, 2022

Pfizer COVID-19 vaccines safe and effective for small children, FDA staff say

A child reacts while receiving a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at Smoketown Family Wellness Center in Louisville, Kentucky, U.S., November 8, 2021. REUTERS

U.S. Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech’s, COVID-19 vaccines were effective and safe for use in children aged 6 months to 4 years.

The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.

Article continues after this advertisement

The FDA analysis of data from Pfizer’s trial was published ahead of a June 15 meeting of its outside advisers. Recommendations from the external advisers will determine the FDA’s decision on the vaccines.

FEATURED STORIES

“Available data support the effectiveness of the Pfizer-BioNTech COVID-19 Vaccine 3-dose primary series in preventing COVID-19 in the age group of 6 months through 4 years,” FDA staff said in the review.

An early analysis of data from Pfizer-BioNTech’s vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was dominant suggested a vaccine efficacy of 80.3% in the under-5 age group.

Article continues after this advertisement

COVID-19 shots for children under the age of 6 are yet not approved in most parts of the world. It remains unclear how many parents will get their young ones vaccinated as demand has been low for kids aged 5 to 11.

Article continues after this advertisement

U.S. President Joe Biden’s administration expects vaccinations for young children to begin in earnest as early as June 21 if the FDA and the Centers for Disease Control and Prevention approve the vaccines.

Article continues after this advertisement

Government officials say pre-orders for use in the under-6 age group has been low but demand is expected to pick up once the vaccines gain authorization.

The FDA on Friday released a staff review of Moderna Inc’s (MRNA.O) COVID-19 vaccine which said the doses were safe and effective for use in children aged 6 months to 17 years old.

Article continues after this advertisement

RELATED STORIES

780,000 doses of Pfizer COVID-19 vaccine for kids aged 5 – 11 arrive in PH

Pfizer commits 30M COVID-19 vaccine doses for kids aged 5 to 11

More than 900,000 doses of COVID-19 vaccine for kids arrive in PH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

10M doses of Pfizer vaccines for kids to arrive by 2nd quarter of 2022

TAGS: Children, Pfizer, US FDA

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.